Synpromics Ltd company
Synpromics develops and commercializes synthetic promoters to control gene expressions and regulations. The company was founded in 2010 and is based in Edinburgh, United Kingdom.
Technology:
Regenerative Medicine
Industry:
Personalized Medicine
Headquarters:
Edinburgh, Edinburgh, City of, United Kingdom
Founded Date:
2010
Employees Number:
1-10
Funding Status:
N/A
Investors Number:
3
Total Funding:
£9.2M
Estimated Revenue:
$1M to $10M
Last Funding Type:
Grant
Register and Claim Ownership